A novel low molecular weight nanocomposite hydrogel formulation for intra-tumoural delivery of anti-cancer drugs

This publication has 75 references indexed in Scilit:

• Preclinical Absorption, Distribution, Metabolism, and Excretion of an Oral Amide Prodrug of Gemcitabine Designed to Deliver Prolonged Systemic Exposure
  Pharmaceutics, 2013
• In Situ Formation of Steroidal Supramolecular Gels Designed for Drug Release
  Molecules, 2013
• Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment
  European Journal of Pharmaceutics and Biopharmaceutics, 2013
• Formation of Hybrid Hydrogels Consisting of Tripeptide and Different Silver Nanoparticle-Capped Ligands: Modulation of the Mechanical Strength of Gel Phase Materials
  The Journal of Physical Chemistry B, 2012
• Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
  Nature Nanotechnology, 2012
• Local drug delivery strategies for cancer treatment: Gels, nanoparticles, polymeric films, rods, and wafers
  Journal of Controlled Release, 2012
• Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
  Nature Nanotechnology, 2011
• Overcoming drug resistance in pancreatic cancer
  Expert Opinion on Therapeutic Targets, 2011
• CD44‐positive cells are responsible for gemcitabine resistance in pancreatic cancer cells
  International Journal of Cancer, 2009
• The effect of particle design on cellular internalization pathways
  Proceedings of the National Academy of Sciences, 2008